Literature DB >> 20010089

Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think...

Dominique Elias1, Jérémie H Lefevre, Pierre Duvillard, Diane Goéré, Clarisse Dromain, Frédéric Dumont, Eric Baudin.   

Abstract

OBJECTIVES: To prospectively compare the results of the pathologic examination including thin 3- to 4-mm thick serial slices of the surgical specimen in a well-defined anatomic part of the liver with those of 4 different liver imaging techniques. BACKGROUNDS SUMMARY DATA: Liver metastases (LM) of neuroendocrine origin are frequent and accuracy of pretherapeutic liver imaging in detecting small-sized LM is questioned, but no study has compared the different techniques used to image large liver specimens and meticulous pathologic examination. PATIENTS AND METHODS: Eleven patients with a metastatic endocrine tumor were selected before undergoing a right hepatectomy or a left hepatectomy passing along the median hepatic vein. Before the hepatectomy, patients underwent somatostatin receptor scintigraphy, computed tomography, magnetic resonance imaging, and ultrasonography (US). An intraoperative assessment (palpation and US) was also performed. Liver specimens were systematically cut into thin serial slices, 3- to 4-mm thick. A final histologic count of the total number of LM was obtained and compared with findings from each imaging technique.
RESULTS: Compared with the final histologic count of LM, fewer than 50% of the LM were detected preoperatively. The accuracy was 24% for somatostatin receptor scintigraphy, 38% for computed tomography and US, and 49% for magnetic resonance imaging (the only imaging technique that detected half the number of LM). The size of the smallest LM was not greater than 2 mm in 54% of the patients.
CONCLUSION: Half the number of LM from neuroendocrine tumors are undetectable on preoperative imaging.

Entities:  

Mesh:

Year:  2010        PMID: 20010089     DOI: 10.1097/SLA.0b013e3181bdf8cf

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

Review 1.  Carcinoid Tumors: Past, Present, and Future.

Authors:  James R Howe
Journal:  Indian J Surg Oncol       Date:  2020-05-09

2.  Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard.

Authors:  Eduardo A C Costa; Guilherme M Cunha; Emmanuil Smorodinsky; Irene Cruite; An Tang; Robert M Marks; Lisa Clark; Tanya Wolfson; Anthony Gamst; Jason K Sicklick; Alan Hemming; Michael R Peterson; Michael S Middleton; Claude B Sirlin
Journal:  Radiology       Date:  2015-04-15       Impact factor: 11.105

3.  Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization.

Authors:  Yan Luo; Sanaz Ameli; Ankur Pandey; Pegah Khoshpouri; Mounes Aliyari Ghasabeh; Pallavi Pandey; Zhen Li; Daoyu Hu; Ihab R Kamel
Journal:  Eur Radiol       Date:  2019-05-09       Impact factor: 5.315

4.  Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers.

Authors:  Masato Narita; Elie Oussoultzoglou; Marie-Pierre Chenard; Pascal Fuchshuber; Tetsuro Yamamoto; Pietro Addeo; Daniel Jaeck; Philippe Bachellier
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

5.  The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.

Authors:  James R Howe; Nipun B Merchant; Claudius Conrad; Xavier M Keutgen; Julie Hallet; Jeffrey A Drebin; Rebecca M Minter; Terry C Lairmore; Jennifer F Tseng; Herbert J Zeh; Steven K Libutti; Gagandeep Singh; Jeffrey E Lee; Thomas A Hope; Michelle K Kim; Yusuf Menda; Thorvardur R Halfdanarson; Jennifer A Chan; Rodney F Pommier
Journal:  Pancreas       Date:  2020-01       Impact factor: 3.327

Review 6.  The Landmark Series: Neuroendocrine Tumor Liver Metastases.

Authors:  Alexandra Gangi; James R Howe
Journal:  Ann Surg Oncol       Date:  2020-07-06       Impact factor: 5.344

7.  MR visible localization device for radiographic-pathologic correlation of surgical specimens.

Authors:  Sonja Kinner; Tilman B Schubert; Elisabetta A Nocerino; Shannon Hynes; Timothy J Colgan; Agnes G Loeffler; Christopher Brace; Scott B Reeder; Emily Winslow
Journal:  Magn Reson Imaging       Date:  2016-11-27       Impact factor: 2.546

Review 8.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

Review 9.  Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

Authors:  Skye C Mayo; Joseph M Herman; David Cosgrove; Nik Bhagat; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2012-10-11       Impact factor: 6.113

10.  Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.

Authors:  Liliana Chiorean; Adrian Bartos; Doris Pelau; Dana Iancu; Tudor Ciuleanu; Rares Buiga; Irinel Oancea; Angelica Mangrau; Cornel Iancu; Radu Badea
Journal:  J Med Ultrason (2001)       Date:  2014-10-25       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.